Canadian Arthritis Patient Alliance (CAPA) was offered an opportunity to provide feedback related to Health Canada’s Consultation: Handbook for healthcare professionals on biosimilar biologic drugs. CAPA has a Medical Advisory Committee (MAC), and all of our resources...
Have you considered or been approached about switching from a biologic to a biosimilar for helping manage your inflammatory arthritis? This video about biosimilars may help you understand more about biologics and biosimilars and to have a conversation with your...
Are you considering talking to your healthcare provider about biosimilars or has your healthcare provider talked to you already about biosimilars? As people who live with arthritis, we put together some questions reviewed by our Medical Advisory Committee that might...
